Ultimately, a comprehensive understanding of the role of TIM-3 and other immune checkpoint molecules in the pathophysiology of sepsis is essential for the development of innovative therapeutic strategies aimed at enhancing outcomes for sepsis patients. Here, HAVCR2 is linked to Sepsis.